About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

Breakthrough treatment for skin infections?

European Coalition for Access to Comprehensive Genomic Profiling launched

Sarepta gets approval for first gene therapy for Duchenne muscular dystrophy

SandboxAQ launches new division to boost drug development

Alchemab Therapeutics unveils Alzheimer’s candidate  

Ovarian cancer study finds key genes for potential treatments

ADVERTISEMENT

FDA approves type 2 diabetes drug for children 10 and older

Nanobody company Attovia Therapeutics launches with $60M  

FDA clears T-Cell receptor natural killer cell therapy for sarcoma

NodThera announces positive inflammatory disease data

Lighting up cancer: FluoGuide announces positive results from head & neck cancer trial

FDA puts hold on Arcellx myeloma program following patient death

ADVERTISEMENT